Brent Hatzis-Schoch - Officer Title: Chief Operating Officer and General Counsel at Black Diamond Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Officer Title: Chief Operating Officer and General Counsel
Issuer Symbol
BDTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brent Hatzis-Schoch since 12 Mar 2025

Holdings reported by Brent Hatzis-Schoch for Black Diamond Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 83,400 $208,500 $2.50 30 Jan 2025 Direct
Stock Option (Right to Buy) 250,000 21 Jan 2026 Direct Common Stock

Transactions reported by Brent Hatzis-Schoch for Black Diamond Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.